These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16283412)

  • 1. Modelling the effect of a booster vaccination on disease epidemiology.
    Alexander ME; Moghadas SM; Rohani P; Summers AR
    J Math Biol; 2006 Mar; 52(3):290-306. PubMed ID: 16283412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple dose vaccination against childhood diseases: high coverage with the first dose remains crucial for eradication.
    Paulo AC; Gomes MC; Casinhas AC; Horta A; Domingos T
    IMA J Math Appl Med Biol; 2000 Sep; 17(3):201-12. PubMed ID: 11103718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness assessment of vaccination policy against measles epidemic in Japan using an age-time two-dimensional mathematical model.
    Maitani Y; Ishikawa H
    Environ Health Prev Med; 2012 Jan; 17(1):34-43. PubMed ID: 21553196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness.
    Murray M; Rasmussen Z
    Am J Epidemiol; 2000 Apr; 151(8):811-9. PubMed ID: 10965978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population.
    van Boven M; Kretzschmar M; Wallinga J; O'Neill PD; Wichmann O; Hahné S
    J R Soc Interface; 2010 Nov; 7(52):1537-44. PubMed ID: 20392713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination and herd immunity to infectious diseases.
    Anderson RM; May RM
    Nature; 1985 Nov 28-Dec 4; 318(6044):323-9. PubMed ID: 3906406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards eradication of measles virus: global progress and strategy evaluation.
    Nokes DJ; Williams JR; Butler AR
    Vet Microbiol; 1995 May; 44(2-4):333-50. PubMed ID: 8588328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical analysis of a measles transmission dynamics model in Bangladesh with double dose vaccination.
    Kuddus MA; Mohiuddin M; Rahman A
    Sci Rep; 2021 Aug; 11(1):16571. PubMed ID: 34400667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
    Monath TP; Nasidi A
    Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    Smetana J; Chlibek R; Hanovcova I; Sosovickova R; Smetanova L; Gal P; Dite P
    PLoS One; 2017; 12(1):e0170257. PubMed ID: 28085960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles in Pakistan: Time to make steps towards eradication.
    Rehman IU; Bukhsh A; Khan TM
    Travel Med Infect Dis; 2017; 18():67-69. PubMed ID: 28842213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiologic effectiveness of mass revaccination against measles].
    Deshevoĭ SE; Rykushin IuP; Ovsiannikova IV; Malykhina RM; Pogorelyĭ IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):69-72. PubMed ID: 2973716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination for communicable endemic diseases: optimal allocation of initial and booster vaccine doses.
    Rao IJ; Brandeau ML
    J Math Biol; 2024 Jun; 89(2):21. PubMed ID: 38926228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.